ARTICLE | Company News
Encelle other research news
August 28, 2000 7:00 AM UTC
Encelle received a $100,000 Phase I SBIR grant from the National Institute of General Medical Sciences to develop its injectable biopolymer hydrogel matrix, which promotes vascularization, for use in ...